Clinical Trial Update: Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is not yet recruiting, evaluating neoadjuvant androgen deprivation therapy in localized high-risk prostate cancer, using 18F-Flotufolas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Localized Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Androgen deprivation therapy (ADT) (Androgen deprivation therapy)

Snippet

Sponsor: Baptist Health South Florida | Conditions: Prostate Cancer, Localized Prostate Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING